Earlier reopening of the province to step 3

The government announced today an earlier reopening of the province to step 3. The news did not come as a surprise given the successful vaccination rollout and decreased hospitalization rates. In several media interviews I expressed that although the five day advanced reopening is not a major concern, the lack of capacity restrictions in indoor activities is.

RNAO’s continuing media profile: The June report

This month, RNAO spoke out on a number of prominent issues in the media including COVID-19 vaccinations, the province’s reopening framework, the ineffectiveness of signing bonuses for new staff, the urgency to repeal Bill 124, and the welcoming of Ontario’s new Chief Medical Officer of Health Dr. Kieran Moore.

The world is at risk of 'vaccine apartheid'

This week we consider the shocking status of vaccine inequity from a global perspective. World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus said recently that the world is at risk of 'vaccine apartheid'. The WHO chief highlighted that at least 63 million doses of vaccines have been shipped to 124 countries and economies, but they represent just 0.5 per cent of the combined population of those nations. He also noted that the basic problem of vaccine inequity was a lack of sharing by the wealthy countries that have accumulated most of the vaccine supplies.

Canada is virtue signalling while waffling on global access to COVID-19 vaccines

This article addresses the shocking contrast between Canada's declarations of concern with the global distribution of vaccines, and the poor reality of its actions. Joel Lexchin, Professor Emeritus of Health Policy and Management, York University, Emergency Physician at University Health Network, Associate Professor of Family and Community Medicine, University of Toronto tackles this question.

Global herd immunity remains out of reach because of inequitable vaccine distribution – 99% of people in poor countries are unvaccinated

As we reach enormously successful levels of COVID-19 inoculation in Canada and other rich countries, the disparities with the rest of the world become starker. This article considers the enormous cost in lives of leaving most of the global population unvaccinated. It draws lessons on how we can do better from the effort to provide lifesaving drugs for HIV-AIDS in the 1990s. This June 22 article is by Maria De Jesus, Associate Professor and Research Fellow at the Center on Health, Risk, and Society, American University School of International Service.